The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Submission Process and Features - Introductory Video Series
-
If you have not yet seen them, check out our 4 part video series on Upcoming Submission Process and Features
The videos act as bite sized summaries of the changes coming to the PAAB submission process with the introduction of the Accelerated Review Options (ARO).
Video 1: What is ARO?
Video 2: What's new?
Video 3: Submission Fees
Video 4: Other ResourcesLet us know what you think below.
